Literature DB >> 19361856

Should the CD4 threshold for starting ART be raised?

Robin Wood1, Stephen D Lawn.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19361856     DOI: 10.1016/S0140-6736(09)60654-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection.

Authors:  Judith J Lok; Ronald J Bosch; Constance A Benson; Ann C Collier; Gregory K Robbins; Robert W Shafer; Michael D Hughes
Journal:  AIDS       Date:  2010-07-31       Impact factor: 4.177

2.  Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients.

Authors:  Judith J Lok; Victor DeGruttola
Journal:  Biometrics       Date:  2012-02-21       Impact factor: 2.571

Review 3.  When to start antiretroviral therapy.

Authors:  Vivek Jain; Steven G Deeks
Journal:  Curr HIV/AIDS Rep       Date:  2010-05       Impact factor: 5.071

4.  Characterizing the HIV epidemic in the prairie provinces.

Authors:  Marissa L Becker; Ken Kasper; Carla Pindera; Mary Cheang; Debbie Rodger; Stephen Sanche; Stuart Skinner; M John Gill
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

5.  Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period.

Authors:  Fred Kyeyune; Immaculate Nankya; Samar Metha; Juliet Akao; Emmanuel Ndashimye; Denis M Tebit; Benigno Rodriguez; Cissy Kityo; Robert A Salata; Peter Mugyenyi; Eric Arts
Journal:  AIDS       Date:  2013-07-31       Impact factor: 4.177

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.